Reveal your drug’s anti-inflammatory and beta cell protection potential

Using Endoc-BH5® cells, the Cytokine-Mediated Human Beta Cell Inflammation Assay replicates in vitro the clinically observed response of human pancreatic beta cells to cytokine-induced inflammation process observed in Type 2 and Type 1 Diabetes.

Key advantages:

• Translational model
• Recapitulate diabetes progression, from early inflammation-induced cell dysfunction to apoptosis
• Acute and chronic treatment compatible (>3 weeks)
• Multiparametric model (function, inflammation, death readouts)
• HTS compatible

Discover how this assay will enable you to evaluate the anti-inflammatory and beta cell protection potential of your drug compounds.